This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Al Bitar S., Gali-Muhtasib H.: The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics. Cancers 2019, 11, 1475, doi: 10.3390/cancers11101475.Al BitarS.Gali-MuhtasibH.: The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics. Cancers2019, 11, 1475, doi: 10.3390/cancers11101475.Open DOISearch in Google Scholar
Blackwood L., Murphy S., Buracco P., De Vos J.P., De Fornel-Thibaud P., Hirschberger J., Kessler M., Pastor J., Ponce F., Savary-Bataille K., Argyle D.J.: European consensus document on mast cell tumours in dogs and cats. Vet Comp Oncol 2012, 10, e1–e29, doi: 10.1111/j.1476-5829.2012.00341.x.BlackwoodL.MurphyS.BuraccoP.De VosJ.P.De Fornel-ThibaudP.HirschbergerJ.KesslerM.PastorJ.PonceF.Savary-BatailleK.ArgyleD.J.: European consensus document on mast cell tumours in dogs and cats. Vet Comp Oncol2012, 10, e1–e29, doi: 10.1111/j.1476-5829.2012.00341.x.Open DOISearch in Google Scholar
Bonnans C., Chou J., Werb Z.: Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 2014, 15, 786–801, doi: 10.1038/nrm3904.BonnansC.ChouJ.WerbZ.: Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol2014, 15, 786–801, doi: 10.1038/nrm3904.Open DOISearch in Google Scholar
Campora L., Miragliotta V., Ricci E., Cristino L., Di Marzo V., Albanese F., Federica Della Valle M., Abramo F.: Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis. Am J Vet Res 2012, 73, 988–995, doi: 10.2460/ajvr.73.7.988.CamporaL.MiragliottaV.RicciE.CristinoL.Di MarzoV.AlbaneseF.Federica Della ValleM.AbramoF.: Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis. Am J Vet Res2012, 73, 988–995, doi: 10.2460/ajvr.73.7.988.Open DOISearch in Google Scholar
Capparelli C., Chiavarina B., Whitaker-Menezes D., Pestell T.G., Pestell R.G., Hulit J., Andò S., Howell A., Martinez-Outschoorn U.E., Sotgia F., Lisanti M.P.: CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle 2012, 11, 3599–3610, doi: 10.4161/cc.21884.CapparelliC.ChiavarinaB.Whitaker-MenezesD.PestellT.G.PestellR.G.HulitJ.AndòS.HowellA.Martinez-OutschoornU.E.SotgiaF.LisantiM.P.: CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle2012, 11, 3599–3610, doi: 10.4161/cc.21884.Open DOISearch in Google Scholar
Coussens L.M., Fingleton B., Matrisian L.M.: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002, 295, 2387–2392, doi: 10.1126/science.1067100.CoussensL.M.FingletonB.MatrisianL.M.: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science2002, 295, 2387–2392, doi: 10.1126/science.1067100.Open DOISearch in Google Scholar
Daniel J., Barra C.N., Pulz L.H., Kleeb S.R., Xavier J.G., Catão-Dias J.L., Nishiya A.T., Fukumasu H., Strefezzi R.F.: Intratumoral collagen index predicts mortality and survival in canine cutaneous mast cell tumours. Vet Dermatol 2019, 30, 162–e48, doi: 10.1111/vde.12726.DanielJ.BarraC.N.PulzL.H.KleebS.R.XavierJ.G.Catão-DiasJ.L.NishiyaA.T.FukumasuH.StrefezziR.F.: Intratumoral collagen index predicts mortality and survival in canine cutaneous mast cell tumours. Vet Dermatol2019, 30, 162–e48, doi: 10.1111/vde.12726.Open DOISearch in Google Scholar
De Nardi A.B.D., Horta R.D.S., Fonseca-Alves C.E., Paiva F.N.D., Linhares L.C.M., Firmo B.F., Sueiro F.A.R., Oliveira K.D.D., Lourenço S.V., Strefezzi R.D.F., Brunner C.H.M., Rangel M.M.M., Jark P.C., Castro J.L.C., Ubukata R., Batschinski K., Sobral R.A., Cruz N.O.D., Nishiya A.T., Fernandes S.C., Cunha S.C.D.S., Gerardi D.G., Challoub G.S.G., Biondi L.R., Laufer-Amorim R., Paes P.R.D.O., Lavalle G.E., Huppes R.R., Grandi F., Vasconcellos C.H.D.C., Anjos D.S.D., Luzo Â.C.M., Matera J.M., Vozdova M., Dagli M.L.Z.: Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors. Cells 2022, 11, 1–37, doi: 10.3390/cells11040618.De NardiA.B.D.HortaR.D.S.Fonseca-AlvesC.E.PaivaF.N.D.LinharesL.C.M.FirmoB.F.SueiroF.A.R.OliveiraK.D.D.LourençoS.V.StrefezziR.D.F.BrunnerC.H.M.RangelM.M.M.JarkP.C.CastroJ.L.C.UbukataR.BatschinskiK.SobralR.A.CruzN.O.D.NishiyaA.T.FernandesS.C.CunhaS.C.D.S.GerardiD.G.ChalloubG.S.G.BiondiL.R.Laufer-AmorimR.PaesP.R.D.O.LavalleG.E.HuppesR.R.GrandiF.VasconcellosC.H.D.C.AnjosD.S.D.LuzoÂ.C.M.MateraJ.M.VozdovaM.DagliM.L.Z.: Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors. Cells2022, 11, 1–37, doi: 10.3390/cells11040618.Open DOISearch in Google Scholar
Dhopeshwarkar A., Mackie K.: CB2 Cannabinoid receptors as a therapeutic target – what does the future hold? Mol Pharmacol 2014, 86, 430–437, doi: 10.1124/mol.114.094649.DhopeshwarkarA.MackieK.: CB2 Cannabinoid receptors as a therapeutic target – what does the future hold?Mol Pharmacol2014, 86, 430–437, doi: 10.1124/mol.114.094649.Open DOISearch in Google Scholar
Di Girolamo N., Wakefield D.: In vitro and in vivo expression of interstitial collagenase/MMP-1 by human mast cells. Dev Immunol 2000, 7, 131–142, doi: 10.1155/2000/82708.Di GirolamoN.WakefieldD.: In vitro and in vivo expression of interstitial collagenase/MMP-1 by human mast cells. Dev Immunol2000, 7, 131–142, doi: 10.1155/2000/82708.Open DOISearch in Google Scholar
Galietta V., Parisi F., Cocumelli C., Pierini A., Poli A., Scaramozzino P., Spallucci V., Millanta F.: Preliminary Assessment of Tumor-Associated Tissue Eosinophilia (TATE) in Canine Mast Cell Tumors: Prevalence and Prognostic Relevance and Its Association with Neoangiogenesis. Animals 2023, 13, 283, doi: 10.3390/ani13020283.GaliettaV.ParisiF.CocumelliC.PieriniA.PoliA.ScaramozzinoP.SpallucciV.MillantaF.: Preliminary Assessment of Tumor-Associated Tissue Eosinophilia (TATE) in Canine Mast Cell Tumors: Prevalence and Prognostic Relevance and Its Association with Neoangiogenesis. Animals2023, 13, 283, doi: 10.3390/ani13020283.Open DOISearch in Google Scholar
Gartel A.L., Tyner A.L.: The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis. Mol Cancer Ther 2002, 1, 639–649.GartelA.L.TynerA.L.: The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis. Mol Cancer Ther2002, 1, 639–649.Search in Google Scholar
Johansson N., Ahonen M., Kähäri V.M.: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000, 57, 5–15, doi: 10.1007/s000180050495.JohanssonN.AhonenM.KähäriV.M.: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci2000, 57, 5–15, doi: 10.1007/s000180050495.Open DOISearch in Google Scholar
Kim E.M., Jung C.-H., Kim J., Hwang S.-G., Park J.K., Um H.-D.: The p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins. Cancer Res 2017, 77, 3092–3100, doi: 10.1158/0008-5472.CAN-16-2098.KimE.M.JungC.-H.KimJ.HwangS.-G.ParkJ.K.UmH.-D.: The p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins. Cancer Res2017, 77, 3092–3100, doi: 10.1158/0008-5472.CAN-16-2098.Open DOISearch in Google Scholar
Komi D.E.A., Redegeld F.A.: Role of Mast Cells in Shaping the Tumor Microenvironment. Clin Rev Allergy Immunol 2020, 58, 313–325, doi: 10.1007/s12016-019-08753-w.KomiD.E.A.RedegeldF.A.: Role of Mast Cells in Shaping the Tumor Microenvironment. Clin Rev Allergy Immunol2020, 58, 313–325, doi: 10.1007/s12016-019-08753-w.Open DOISearch in Google Scholar
Manzoor S., Saif R., Sadia H., Firyal S., Tayyab M., Mansha M., Mahmood A.K., Hashmi A.S., Awan A.R., Wasim M.: Molecular expression of cyclin dependent kinase inhibitor (p21) in canine tumors. J Anim Plant Sci 2019, 29, 1127–1134.ManzoorS.SaifR.SadiaH.FiryalS.TayyabM.ManshaM.MahmoodA.K.HashmiA.S.AwanA.R.WasimM.: Molecular expression of cyclin dependent kinase inhibitor (p21) in canine tumors. J Anim Plant Sci2019, 29, 1127–1134.Search in Google Scholar
Page-McCaw A., Ewald A.J., Werb Z.: Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol 2007, 8, 221–233, doi: 10.1038/nrm2125.Page-McCawA.EwaldA.J.WerbZ.: Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol2007, 8, 221–233, doi: 10.1038/nrm2125.Open DOISearch in Google Scholar
Parveen A., Akash M.S., Rehman K., Kyunn W.W.: Dual Role of p21 in the Progression of Cancer and Its Treatment. Crit Rev Eukaryot Gene Expr 2016, 26, 49–62, doi: 10.1615/CritRevEukaryotGeneExpr.v26.i1.60.ParveenA.AkashM.S.RehmanK.KyunnW.W.: Dual Role of p21 in the Progression of Cancer and Its Treatment. Crit Rev Eukaryot Gene Expr2016, 26, 49–62, doi: 10.1615/CritRevEukaryotGeneExpr.v26.i1.60.Open DOISearch in Google Scholar
Patnaik A.K., Ehler W.J., MacEwen E.G.: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984, 21, 469–474, doi: 10.1177/030098588402100503.PatnaikA.K.EhlerW.J.MacEwenE.G.: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol1984, 21, 469–474, doi: 10.1177/030098588402100503.Open DOISearch in Google Scholar
Rajamäki M.M., Järvinen A.K., Sorsa T., Maisi P.: Collagenolytic Activity in Bronchoalveolar Lavage Fluid in Canine Pulmonary Eosinophilia. J Vet Intern Med 2002, 16, 658–664, doi: 10.1111/J.1939-1676.2002.TB02404.X.RajamäkiM.M.JärvinenA.K.SorsaT.MaisiP.: Collagenolytic Activity in Bronchoalveolar Lavage Fluid in Canine Pulmonary Eosinophilia. J Vet Intern Med2002, 16, 658–664, doi: 10.1111/J.1939-1676.2002.TB02404.X.Open DOISearch in Google Scholar
Ramer R., Hinz B.: Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst 2008, 100, 59–69, doi: 10.1093/jnci/djm268.RamerR.HinzB.: Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst2008, 100, 59–69, doi: 10.1093/jnci/djm268.Open DOISearch in Google Scholar
Ribatti D.: The Staining of Mast Cells: A Historical Overview. Int Arch Allergy Immunol 2018, 176, 55–60, doi: 10.1159/000487538.RibattiD.: The Staining of Mast Cells: A Historical Overview. Int Arch Allergy Immunol2018, 176, 55–60, doi: 10.1159/000487538.Open DOISearch in Google Scholar
Rinaldi V., Boari A., Ressel L., Bongiovanni L., Crisi P.E., Cabibbo E., Finotello R.: Expression of cannabinoid receptors CB1 and CB2 in canine cutaneous mast cell tumours. Res Vet Sci 2022, 152, 530–536, doi: 10.1016/j.rvsc.2022.09.013.RinaldiV.BoariA.ResselL.BongiovanniL.CrisiP.E.CabibboE.FinotelloR.: Expression of cannabinoid receptors CB1 and CB2 in canine cutaneous mast cell tumours. Res Vet Sci2022, 152, 530–536, doi: 10.1016/j.rvsc.2022.09.013.Open DOISearch in Google Scholar
Sabattini S., Scarpa F., Berlato D., Bettini G.: Histologic grading of canine mast cell tumor: is 2 better than 3? Vet Pathol 2015, 52, 70–73, doi: 10.1177/0300985814521638.SabattiniS.ScarpaF.BerlatoD.BettiniG.: Histologic grading of canine mast cell tumor: is 2 better than 3?Vet Pathol2015, 52, 70–73, doi: 10.1177/0300985814521638.Open DOISearch in Google Scholar
Stamenkovic I.: Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003, 200, 448–464, doi: 10.1002/path.1400.StamenkovicI.: Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol2003, 200, 448–464, doi: 10.1002/path.1400.Open DOISearch in Google Scholar
Theoharides T.C., Alysandratos K.D., Angelidou A., Delivanis D.A., Sismanopoulos N., Zhang B., Asadi S., Vasiadi M., Weng Z., Miniati A., Kalogeromitros D.: Mast cells and inflammation. Biochim Biophys Acta 2012, 1822, 21–33, doi: 10.1016/j.bbadis.2010.12.014.TheoharidesT.C.AlysandratosK.D.AngelidouA.DelivanisD.A.SismanopoulosN.ZhangB.AsadiS.VasiadiM.WengZ.MiniatiA.KalogeromitrosD.: Mast cells and inflammation. Biochim Biophys Acta2012, 1822, 21–33, doi: 10.1016/j.bbadis.2010.12.014.Open DOISearch in Google Scholar
Welle M.M., Bley C.R., Howard J., Rüfenacht S.: Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Vet Dermatol 2008, 19, 321–339, doi: 10.1111/j.1365-3164.2008.00694.x.WelleM.M.BleyC.R.HowardJ.RüfenachtS.: Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Vet Dermatol2008, 19, 321–339, doi: 10.1111/j.1365-3164.2008.00694.x.Open DOISearch in Google Scholar
Willmann M., Hadzijusufovic E., Hermine O., Dacasto M., Marconato L., Bauer K., Peter B., Gamperl S., Eisenwort G., Jensen-Jarolim E., Müller M., Arock M., Vail D.M., Valent P.: Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms. Vet Comp Oncol 2019, 17, 1–10, doi: 10.1111/vco.12440.WillmannM.HadzijusufovicE.HermineO.DacastoM.MarconatoL.BauerK.PeterB.GamperlS.EisenwortG.Jensen-JarolimE.MüllerM.ArockM.VailD.M.ValentP.: Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms. Vet Comp Oncol2019, 17, 1–10, doi: 10.1111/vco.12440.Open DOISearch in Google Scholar
Wu H., Hayashi T., Inoue M.: Immunohistochemical Expression of p27 and p21 in Canine Cutaneous Mast Cell Tumors and Histiocytomas. Vet Path 2004, 41, 296–299, doi: 10.1354/vp.41-3-296.WuH.HayashiT.InoueM.: Immunohistochemical Expression of p27 and p21 in Canine Cutaneous Mast Cell Tumors and Histiocytomas. Vet Path2004, 41, 296–299, doi: 10.1354/vp.41-3-296.Open DOISearch in Google Scholar
Yang Y., Vyawahare R., Lewis-Bakker M., Clarke H.A., Wong A.H.C., Kotra L.P.: Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors. Molecules 2020, 25, 3466, doi: 10.3390/molecules25153466.YangY.VyawahareR.Lewis-BakkerM.ClarkeH.A.WongA.H.C.KotraL.P.: Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors. Molecules2020, 25, 3466, doi: 10.3390/molecules25153466.Open DOISearch in Google Scholar